English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Fixed-dose combinations (FDC) are the future of antihypertensive treatment. Doctors gain more experience in their practical application, as well as witness the introduction of new, complex formulas appearing on the pharmaceutical market that improve patients’ adherence and gradually increase the proportion of subjects with well-controlled blood pressure in Poland. A large number of FDCs appears on the market containing not only two-component formulations, but also those with 3 drugs. Choosing from the many formulations is often hard. This article is intended to answer the question: Why should we use an FDC containing perindopril, indapamide and amlodipine? 10 presented arguments certainly do not exhaust all the advantages of using such a product — but are an indication of why the drug is at the moment one of the most modern, most effective and best tolerated triple combinations available on the Polish pharmaceutical market. Such combination is not only beneficial for patients, but be may soon change the face of pharmacotherapy.

10 powodów, dla których warto wybierać preparat złożony zawierający perindopril, indapamid i amlodipinę w jednej tabletce